<SEC-DOCUMENT>0001062993-23-001061.txt : 20230119
<SEC-HEADER>0001062993-23-001061.hdr.sgml : 20230119
<ACCEPTANCE-DATETIME>20230119095450
ACCESSION NUMBER:		0001062993-23-001061
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20230119
FILED AS OF DATE:		20230119
DATE AS OF CHANGE:		20230119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zentek Ltd.
		CENTRAL INDEX KEY:			0001904501
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS CHEMICAL PRODUCTS [2890]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41310
		FILM NUMBER:		23536146

	BUSINESS ADDRESS:	
		STREET 1:		24 CORPORATE CT
		CITY:			GUELPH
		STATE:			A6
		ZIP:			N1G 5G5
		BUSINESS PHONE:		(844) 730-9822

	MAIL ADDRESS:	
		STREET 1:		24 CORPORATE CT
		CITY:			GUELPH
		STATE:			A6
		ZIP:			N1G 5G5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>Zentek Ltd.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><b>UNITED STATES</b></font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></font></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b>Washington, D.C. 20549</b></p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000;">
    <p style="text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><b>FORM 6-K</b></font></p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000;">
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>REPORT OF FOREIGN PRIVATE ISSUER</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>PURSUANT TO RULE 13a-16 OR 15d-16</b></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: center; background-color: #ffffff;"><b>For the month of <u>January 2023</u></b></p>
    <p style="text-align: center; background-color: #ffffff;"><b>Commission File Number: <u>001-41310</u></b></p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000;">
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><font style="font-size: 18pt;"><u><b>ZENTEK LTD.</b></u></font></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b>(Registrant)</b></p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000;">
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>24 Corporate Court</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><b>Guelph, Ontario N1G 5G5 Canada</b></p>
    <p style="margin-top: 0pt; text-align: center; background-color: #ffffff;"><b> (Address of Principal Executive Offices)</b></p>
    <hr style="border-top-style: none; border-bottom: 0.75pt solid #000000;">
    <p style="background-color: #ffffff; text-align: justify;">Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</p>
    <p style="text-align: center; background-color: #ffffff;">Form 20-F&#160; &#9744;&#160; &#160; &#160; &#160; &#160; &#160; Form 40-F&#160; &#9746;</p>
    <p style="background-color: #ffffff; text-align: justify;">Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160; &#9744;</p>
    <p style="background-color: #ffffff; text-align: justify;">Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160; &#9744;</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="margin-bottom: 0pt; text-align: center; background-color: #ffffff;"><u><b>SIGNATURES</b></u><br><b> </b></p>
    <p style="text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top;" colspan="2"><b>ZENTEK LTD.</b></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; vertical-align: top;" colspan="2">(Registrant)</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%; vertical-align: top;">Date: January 19, 2023</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; vertical-align: top;">By</td>
            <td style="vertical-align: top; background-color: #ffffff; width: 45%; border-bottom: 0.75pt solid #000000;">/s/ Wendy Ford</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%; vertical-align: top;">Wendy Ford</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 50%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 5%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 45%; vertical-align: top;">Chief Financial Officer</td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><u><b>EXHIBIT INDEX</b></u></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="vertical-align: bottom; background-color: #ffffff; width: 10%;"><u><b>Exhibit</b></u></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%;"><u><b>Description of Exhibit</b></u></td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 10%; vertical-align: top;">&#160;</td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; width: 90%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: rgb(238, 238, 238); width: 10%; vertical-align: top;"><a href="exhibit99-1.htm">99.1</a></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: rgb(238, 238, 238); width: 90%; vertical-align: top;"><a href="exhibit99-1.htm">Press Release dated January 19, 2023 - Zentek Signs Distribution Agreement with Southmedic Inc.</a></td>
        </tr>
    </table>
    <br>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>Zentek Ltd.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-align: center;"><img src="exhibit99-1x001.jpg" style="width: 219px;" height="51"></p>
    <p style="text-align: center;"><font style="color: rgb(34, 34, 34); font-size: 14pt;"><b>Zentek</b></font><b><font style="font-size: 14pt;"> Signs Distribution Agreement with Southmedic Inc.</font> </b></p>
    <p style="background-color: #ffffff; text-align: justify;"><b>Guelph, ON - January 19, 2023, Zentek Ltd.</b> ("<b>Zentek</b>" or the "<b>Company</b>") (Nasdaq: ZTEK; TSX-V: ZEN), an intellectual property development and commercialization company, has signed a Distribution Agreement with Southmedic Inc. ("Southmedic") for the distribution of Zentek's patented ZenGUARD&#8482; surgical masks. Under the agreement, Southmedic will be the distributor of ZenGUARD&#8482;-enhanced surgical masks to the Canadian hospital, general practitioner, private surgery, long-term care and nursing home markets.</p>
    <p style="background-color: #ffffff; text-align: justify;">Southmedic is one of the largest independent distributors of medical devices in Canada with a dedicated sales team that supports all Canadian hospitals, clinics and private offices coast to coast. Southmedic currently distributes other personal protective equipment products in Canada and has distribution in over 80 countries globally.&#160; Southmedic has also been recognized as a Platinum Member of Deloitte's Best Managed Companies.</p>
    <p style="background-color: #ffffff; text-align: justify;">"Zentek is proud to partner with a great company like Southmedic. They bring a strong distribution network across Canada and beyond and have a reputation of bringing quality products and innovative solutions to the healthcare space, exactly what our ZenGUARD&#8482; surgical mask brings to the market." said Greg Fenton, CEO of Zentek. "We believe this is a meaningful step toward securing volumes in a market segment with stable demand for surgical masks. While our focus is currently on surgical masks in Canada, we look forward to exploring other opportunities for our ZenGUARD&#8482; platform in the healthcare space with the Southmedic team."</p>
    <p style="background-color: #ffffff; text-align: justify;">Lee McDonald, CEO of Southmedic commented: "At Southmedic, we have built a reputation for providing customer-centric quality products and innovative solutions - and the ZenGUARD&#8482; surgical mask with its antimicrobial properties and superior bacterial and viral filtration efficiency is a natural complement to our Sales team's existing portfolio."</p>
    <p style="background-color: #ffffff; text-align: justify;"><b>About Zentek</b></p>
    <p style="background-color: #ffffff; text-align: justify;">Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond.</p>
    <p style="text-align: justify;">Zentek's patented ZenGUARD&#8482; coating is shown to have 99% antimicrobial activity and to significantly increase the bacterial and viral filtration efficiency of both surgical masks and HVAC systems.&#160; Zentek's ZenGUARD&#8482; production facility is located in Guelph, Ontario.</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;"><b>About Southmedic Inc.</b></p>
    <p style="text-align: justify;"><font style="background-color: #fffffe;">Established in 1983, Southmedic Inc. provides healthcare products, custom manufacturing, and distribution in over 80 countries around the world. Proud to be recognized as a Platinum Member of Deloitte's Best Managed Companies. We believe in Finding a Better Way; through the passion<b>, </b>flexibility, and integrity of our people, we provide customer-centric quality products and innovative solutions. Southmedic's Dream Statement is <b>"</b>to be the only call customers want to make"</font></p>
    <p style="text-align: justify;"><b>For further information: </b></p>
    <p style="background-color: #ffffff; text-align: justify;">Mitch Swergold<br>Tel: (917) 930-8723<br><font style="color: #0000ff;"><u>Email: mswergold@zentek.com </u></font></p>
    <p style="background-color: #ffffff; text-align: justify;">To find out more about Zentek Ltd., please visit our website at <font style="color: #0000ff;"><u>www.Zentek.com</u></font>. A copy of this news release and all material documents in respect of the Company may be obtained on ZEN's SEDAR profile at <font style="color: #0000ff;"><u>http://www.sedar.com/</u></font>.</p>
    <p style="background-color: #ffffff; text-align: justify;"><b>Forward-Looking Statements </b></p>
    <p style="background-color: #ffffff; text-align: justify;">This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.</p>
    <p style="background-color: #ffffff; text-align: justify;">Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exhibit99-1x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1"  S -L# 2(  A$! Q$!_\0
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M5Z]XVUC78_B5HT*:GJ$]VL3:=*2@DD9PI.[G&[%97_#M7Q=_T5#1?_!;+_\
M%5^C5?,?_!13]IVU^#/A%O"OA:YCF\;ZQ ?(VX8:7$>//<=-W]Q3U/)X'/CF
M9^;/[2GPRD^$'Q=U#P'/XBT_7)].2,S75B"JJSH&,;*?NL,C(R>H^E>P?\$J
M_AMXJ\4_M.Z/XSTZQ9=#\)R//J%]*"(]SQ.B1(?XG._..P!)QQGS+]FSX2>,
M?C_\7QHFFR2MYTOVK6M6G!9;6-FRTCGN['.T?Q'\2/V$^"OP[\+_  L^'=AX
M,\(V*VNGV*<MC]Y<2'[TLC?Q.QZG\.@H \7_ ."D/[1,_P $OAS;Z1X:=?\
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'G-6E)L__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
